News & analysis
News & analysis

Oracle results beat Wall Street estimates

14 December 2022 By Klavs Valters

Share

The US software and hardware manufacturer Oracle Corporation (NYSE: ORCL) announced its latest financial results after the market close in the US on Monday.

The company posted solid results for the Fiscal 2023 Q2, beating analyst estimates for revenue and earnings per share (EPS).

Revenue reported at $12.275 billion vs. $11.959 billion expected.

EPS at $1.21 per share for the quarter vs. the $1.17 per share estimate.

“In Q2, Oracle’s total revenue grew 25% in constant currency—exceeding the high end of our guidance by more than $200 million,” CEO of the company, Safra Catz commented on the performance in the quarter.

“That strong overall revenue growth was powered by our infrastructure and applications cloud businesses that grew 59% and 45% respectively, in constant currency. Fusion Cloud ERP grew 28% in constant currency, NetSuite Cloud ERP grew 29% in constant currency—each and every one of our strategic businesses delivered solid revenue growth in the quarter,” Catz concluded.

“Since the acquisition, Cerner has contributed to Oracle’s growth—and Oracle has helped Cerner improve its technology,” Chairman and CTO of Oracle, Larry Ellison said in a press release.

“But we are just beginning our mission to modernize healthcare information systems. In the wake of the COVID pandemic, there is a worldwide sense of urgency to transform and improve national healthcare systems. Our goals are ambitious: fully automate clinical trials to shorten the time it takes to deliver lifesaving new drugs to patients, enable doctors to easily access better information leading to better patient outcomes, and provide public health professionals with an early warning system that locates and identifies new pathogens in time to prevent the next pandemic. The scale of this opportunity is unprecedented—and so is the responsibility that goes along with it,” Ellison added.

The stock was down by around 1% at the market open on Tuesday at $80.27 a share.

Stock performance

  • 1 month: +2.39%
  • 3 months: +6.61%
  • Year-to-date: -7.04%
  • 1 year: -18.84%

Oracle price targets

  • B of A Securities: $95
  • Cowen & Co.: $96
  • Stifel: $75
  • Piper Sandler: $85
  • Keybanc: $94
  • Barclays: $81
  • Deutsche Bank: $120
  • Jefferies: $75
  • Berenberg: $72
  • BMO Capital: $90

Oracle is the 39th largest company in the world with a market cap of $218.09 billion.

You can trade Oracle Corporation (NYSE: ORCL) and many other stocks from the NYSE, NASDAQ, HKEX, ASX, LSE and DE with GO Markets as a Share CFD.

Sources: Oracle Corporation, TradingView, MarketWatch, MetaTrader 5, Benzinga, CompaniesMarketCap

Ready to start trading?

The information provided is of general nature only and does not take into account your personal objectives, financial situations or needs. Before acting on any information provided, you should consider whether the information is suitable for you and your personal circumstances and if necessary, seek appropriate professional advice. All opinions, conclusions, forecasts or recommendations are reasonably held at the time of compilation but are subject to change without notice. Past performance is not an indication of future performance. Go Markets Pty Ltd, ABN 85 081 864 039, AFSL 254963 is a CFD issuer, and trading carries significant risks and is not suitable for everyone. You do not own or have any interest in the rights to the underlying assets. You should consider the appropriateness by reviewing our TMD, FSG, PDS and other CFD legal documents to ensure you understand the risks before you invest in CFDs. These documents are available here.

#Indice #Indices #IndicesTrading #IndexTrading #Shares #Stockmarket #Stocks